BioSpace News Archive

Eagle Telemedicine announced today that its telehospitalists stand ready to support its hospital partners in the path of Hurricane Dorian and throughout hurricane season when other catastrophic storms threaten to disrupt patient care on the East Coast.

Health Recovery Solutions (HRS), a technology company that provides remote patient monitoring for leading health systems, today announced closing $10 million in growth financing led by Edison Partners.

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that it will present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019 in New York City.

Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced the passing of long-time and valued member of the company’s Board of Directors, John H. McArthur.

Medicine Man Technologies, Inc. (MDCL) (“Medicine Man Technologies” or “Company”), today announced that it will be presenting at the Rodman & Renshaw 21st Annual Global Investment Conference, to be held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City.

Veralox Therapeutics (“Veralox”), a preclinical stage company focused on accelerating the development of first-in-class therapeutics for unmet medical needs, today announced it has raised a $5.4 million seed funding round.

PHOENIX Rehabilitation and Health Services announced the acquisition of North Carolina based Black Mountain PT which becomes the company’s 100th location in the US.

111, Inc., a leading integrated online and offline healthcare platform, announced the release of the second episode in its 111 Insight series.

The conference is being held at the Lotte New York Palace Hotel in New York City on September 8-10, 2019.

Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline.